Lv4
750 积分 2023-03-14 加入
Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial
1个月前
已完结
Ponsegromab for the Treatment of Cancer Cachexia
4个月前
已完结
Long-Term Outcomes of Elagolix in Women With Endometriosis
8个月前
已完结
2018年首创性小分子药物研究实例浅析
9个月前
已关闭
Elagolix Alone and With Add-Back Decreases Heavy Menstrual Bleeding in Women With Uterine Fibroids [21H]
9个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
1年前
已完结
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer
1年前
已完结
Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms
1年前
已完结
Pancreatic cancer
1年前
已完结
皖公网安备34019202002308
